chr17-3690428-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002561.4(P2RX5):āc.532G>Cā(p.Glu178Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000756 in 1,455,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002561.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
P2RX5 | NM_002561.4 | c.532G>C | p.Glu178Gln | missense_variant, splice_region_variant | 5/12 | ENST00000225328.10 | |
P2RX5-TAX1BP3 | NR_037928.1 | n.931G>C | splice_region_variant, non_coding_transcript_exon_variant | 5/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
P2RX5 | ENST00000225328.10 | c.532G>C | p.Glu178Gln | missense_variant, splice_region_variant | 5/12 | 1 | NM_002561.4 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000756 AC: 11AN: 1455724Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 4AN XY: 724026
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.532G>C (p.E178Q) alteration is located in exon 5 (coding exon 5) of the P2RX5 gene. This alteration results from a G to C substitution at nucleotide position 532, causing the glutamic acid (E) at amino acid position 178 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at